Jordana E. Hoppe

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials”.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00434-9

N/A

3.9DataRank · unranked

127 citations

Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki +91 more

Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial

The Lancet Respiratory Medicine(2025)10.1016/s2213-2600(24)00407-7

N/A

1.4DataRank · unranked

50 citations

Ajay S. Kasi, Jessica E. Pittman, Renée Jensen, L. Thia, Philip Robinson +44 more

Airway Inflammation in Children with Primary Ciliary Dyskinesia

Annals of the American Thoracic Society(2022)10.1513/annalsats.202204-314oc

N/A

0DataRank · unranked

26 citations

Oren Kupfer, Brandie D. Wagner, Stephanie D. Davis, Sharon Dell, Thomas W. Ferkol +7 more

Effects of ivacaftor on systemic inflammation and the plasma proteome in people with CF and G551D

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.03.012

N/A

0DataRank · unranked

19 citations

Brandie D. Wagner, J. Kirk Harris, Steven M. Rowe, Sonya L. Heltshe, Emily M. DeBoer +2 more

106 Impact of discontinuing hypertonic saline and dornase alfa in people with cystic fibrosis established on elexacaftor-tezacaftor-ivacaftor: A SIMPLIFY ancillary study

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01041-x

N/A

0DataRank · unranked

1 citations

Alex H. Gifford, Margaret Kloster, Richard Russell, Andrew T. Braun, Ronald L. Gibson +9 more

Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa after Elexacaftor-Tezacaftor-Ivacaftor in Cystic Fibrosis

Annals of the American Thoracic Society(2024)10.1513/annalsats.202404-366oc

N/A

0DataRank · unranked

10 citations

Alex H. Gifford, Margaret Kloster, Renee Russell, Andrew T. Braun, Ronald L. Gibson +11 more